146 related articles for article (PubMed ID: 9580803)
1. Panniculitis in association with apomorphine infusion.
Acland KM; Churchyard A; Fletcher CL; Turner K; Lees A; Dowd PM
Br J Dermatol; 1998 Mar; 138(3):480-2. PubMed ID: 9580803
[TBL] [Abstract][Full Text] [Related]
2. Apomorphine-induced eosinophilic panniculitis and hypereosinophilia in Parkinson disease.
Pot C; Oppliger R; Castillo V; Coeytaux A; Hauser C; Burkhard PR
Neurology; 2005 Jan; 64(2):392-3. PubMed ID: 15668455
[No Abstract] [Full Text] [Related]
3. Panniculitis with eosinophilic infiltration due to gabexate mesilate (FOY): possibility of allergic reaction.
Nakayama F
J Dermatol; 1997 Apr; 24(4):235-42. PubMed ID: 9164064
[TBL] [Abstract][Full Text] [Related]
4. Ultrasound treatment of cutaneous side-effects of infused apomorphine: a randomized controlled pilot study.
Poltawski L; Edwards H; Todd A; Watson T; Lees A; James CA
Mov Disord; 2009 Jan; 24(1):115-8. PubMed ID: 19006068
[TBL] [Abstract][Full Text] [Related]
5. The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: a histologic study.
van Laar T; van Hilten B; Neef C; Rutgers AW; Pavel S; Bruijn JA
Mov Disord; 1998 Jan; 13(1):52-5. PubMed ID: 9452326
[TBL] [Abstract][Full Text] [Related]
6. Apomorphine nodules in Parkinson's disease: best practice considerations.
Todd A; James CA
Br J Community Nurs; 2008 Oct; 13(10):457-63. PubMed ID: 19057470
[TBL] [Abstract][Full Text] [Related]
7. Immediate type 1 hypersensitivity to apomorphine: a case report.
Gutiérrez D; Foncubierta A; Espinosa R; Astorga S; Leon A; Fernández S
J Investig Allergol Clin Immunol; 2011; 21(4):325-6. PubMed ID: 21721386
[No Abstract] [Full Text] [Related]
8. Panniculitis associated with subcutaneous apomorphine.
Acland KM; Leslie T; Dowd PM
Hosp Med; 1998 May; 59(5):413-4. PubMed ID: 9722396
[No Abstract] [Full Text] [Related]
9. [Continuous subcutaneous infusion of apomorphine in Parkinson's disease: retrospective analysis of a series of 81 patients].
Rambour M; Moreau C; Salleron J; Devos D; Kreisler A; Mutez E; Simonin C; Annic A; Dujardin K; Destée A; Defebvre L
Rev Neurol (Paris); 2014 Mar; 170(3):205-15. PubMed ID: 24594365
[TBL] [Abstract][Full Text] [Related]
10. [Apomorphine hyperpigmentation].
Loewe R; Püspök-Schwarz M; Petzelbauer P
Hautarzt; 2003 Jan; 54(1):58-63. PubMed ID: 12567259
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of apomorphine infusion adverse effects: subcutaneous nodules and neuropsychiatric complications].
Giménez de Béjar V; Carballo-Cordero M
Rev Neurol; 2012; 55 Suppl 1():S25-9. PubMed ID: 23169230
[TBL] [Abstract][Full Text] [Related]
12. Factitial panniculitis.
Sanmartín O; Requena C; Requena L
Dermatol Clin; 2008 Oct; 26(4):519-27, viii. PubMed ID: 18793986
[TBL] [Abstract][Full Text] [Related]
13. Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients.
Camgrand E; Christine BC; Harroch E; Chouquet C; Barthelemy C; Ory-Magne F; Leung C; Barbosa RP; Rascol O; Fabbri M
Parkinsonism Relat Disord; 2023 Nov; 116():105859. PubMed ID: 37788512
[No Abstract] [Full Text] [Related]
14. [Cutaneous necrosis at apomorphine injection points].
Dadban A; Bessis D; Luong MS; Portet F; Guillot B
Ann Dermatol Venereol; 2010 Nov; 137(11):730-5. PubMed ID: 21074659
[TBL] [Abstract][Full Text] [Related]
15. Neutrophilic panniculitis with vasculitis in a melanoma patient treated with vemurafenib: a case report and its management.
Ueno M; Namiki T; Inui K; Hanafusa T; Miura K; Yokozeki H
Int J Dermatol; 2017 Aug; 56(8):e163-e165. PubMed ID: 28244062
[No Abstract] [Full Text] [Related]
16. [Recurrent neutrophilic panniculitis in a patient with chronic myelogenous leukaemia treated with imatinib mesilate and dasatinib].
de Masson A; Bouvresse S; Clérici T; Mahé E; Saïag P
Ann Dermatol Venereol; 2011 Feb; 138(2):135-9. PubMed ID: 21333826
[TBL] [Abstract][Full Text] [Related]
17. BRAFi-associated panniculitis - an emerging side effect with a variable histological picture: report of two cases and review of the literature.
Ferreira J; Toda-Brito H; Moura MC; Sachse MF; Costa-Rosa J
J Cutan Pathol; 2017 Mar; 44(3):307-309. PubMed ID: 27976808
[No Abstract] [Full Text] [Related]
18. Continuous perioperative apomorphine in deep brain stimulation surgery for Parkinson's disease.
Slotty PJ; Wille C; Kinfe TM; Vesper J
Br J Neurosurg; 2014 Jun; 28(3):378-82. PubMed ID: 24073755
[TBL] [Abstract][Full Text] [Related]
19. Apomorphine monotherapy in the treatment of refractory motor complications of Parkinson's disease: long-term follow-up study of 64 patients.
Manson AJ; Turner K; Lees AJ
Mov Disord; 2002 Nov; 17(6):1235-41. PubMed ID: 12465062
[TBL] [Abstract][Full Text] [Related]
20. [Panniculitis induced by MINE chemotherapy].
Saint-Cyr I; Vezon G; Boisseau-Garsaud AM; Calès-Quist D; Panelatti G; Ossondo M
Ann Dermatol Venereol; 2001; 128(6-7):756-8. PubMed ID: 11460041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
